This is topic 2010 ASCO Annual Meeting in forum Hot Stocks Free for All ! at Allstocks.com's Bulletin Board. To visit this topic, use this URL:http://www.allstocks.com/stockmessageboard/ubb/ultimatebb.php/ubb/get_topic/f/2/t/015772.html Posted by Happy Valley on April 11, 2010 18:50 :
ASCO is quickly approaching (June 4-8)...Post your ASCO stocks here...http://chicago2010.asco.org/Home.aspx
Posted by Happy Valley on April 11, 2010 18:52 :
PVCT $1.52 Phase 2 Data on Provectus's PV-10 To Be Presented at the 2010 ASCO Scientific Program on June 4 - 8 in Chicagohttp://finance.yahoo.com/news/Phase-2-Data-on-Provectuss-bw-958042426.html?x=0&. v=1
Posted by Happy Valley on April 11, 2010 18:55 :
CLDX $6.88 Nice pipeline and has a history of popping into ASCO...DYODDhttp://www.celldextherapeutics.com/wt/page/trials_cancer
Posted by Happy Valley on April 11, 2010 19:19 :
CYCC $2.39http://www.cyclacel.com/cyc/ourcompany/pipeline/ Presenting at AACR April 17th-21st... Cyclacel Pharmaceuticals Announces Multiple Abstracts Selected for Presentation at American Association for Cancer Research Annual Meeting Translational Studies Highlight Unique Mechanism of Action and New Potential Clinical Applications for Sapacitabine and Seliciclib http://finance.yahoo.com/news/Cyclacel-Pharmaceuticals-pz-3996680954.html?x=0&.v =1
Posted by Happy Valley on April 12, 2010 08:24 :
KERXhttp://seekingalpha.com/article/198045-keryx-biopharmaceuticals-could-easily-tri ple-within-the-next-year
Posted by Happy Valley on April 12, 2010 13:38 :
THLD $1.88...http://www.thresholdpharm.com/sec/clinical_trials
Posted by Happy Valley on April 12, 2010 13:40 :
MYRX $4.98http://www.myriadpharma.com/product-pipeline/clinical
Posted by Happy Valley on April 12, 2010 18:01 :
quote: Originally posted by Happy Valley: KERXhttp://seekingalpha.com/article/198045-keryx-biopharmaceuticals-could-easily-tri ple-within-the-next-year KERX continuing to romp in AH's...Cancer plays will be hot up til ASCO...JMO DYODD Keryx Biopharmaceuticals, Inc.(NasdaqCM: KERX) After Hours: 4.55 0.28 (6.56%) 5:37pm ET Last Trade: 4.27 Trade Time: 4:00pm ET Change: 0.80 (23.05%) Prev Close: 3.47 Open: 3.72 Bid: 4.46 x 800 Ask: 4.58 x 1500 1y Target Est: 5.75 Day's Range: 3.70 - 4.30 52wk Range: 0.15 - 4.30 Volume: 13,341,371 Avg Vol (3m): 1,790,500 Market Cap: 242.80M P/E (ttm): 20.53 EPS (ttm): 0.21 Div & Yield: N/A (N/A
Posted by Happy Valley on April 12, 2010 19:48 :
ARRY $2.77http://www.arraybiopharma.com/ProductPipeline/Default.asp Array BioPharma Announces Eight Abstracts Selected for Presentation at 2010 AACR Annual Meetinghttp://finance.yahoo.com/news/Array-BioPharma-Announces-bw-1040372837.html?x=0&. v=1
Posted by Happy Valley on April 12, 2010 19:54 :
AEZS $1.00http://www.aezsinc.com/en/page.php?p=12 http://finance.yahoo.com/news/terna-Zentaris-Announces-prnews-3919667711.html?x= 0&.v=1
Posted by Happy Valley on April 13, 2010 20:25 :
DCTH $9.58 Delcath's Phase III Trial Data to be Presented During American Society of Clinical Oncology 2010 Annual Meeting in Chicagohttp://finance.yahoo.com/news/Delcaths-Phase-III-Trial-Data-prnews-220279443.htm l?x=0&.v=1
Posted by Happy Valley on April 13, 2010 20:36 :
PPHM $3.89 Peregrine Announces Data From Four Clinical Studies Will Be Presented at 2010 ASCO Annual Meeting Will Include Data From Bavituximab Breast and Non-Small Cell Lung Cancer Phase II Studies and Cotara Brain Cancer Study http://finance.yahoo.com/news/Peregrine-Announces-Data-From-iw-3980336796.html?x =0&.v=1
Posted by Happy Valley on April 14, 2010 13:57 :
quote: Originally posted by Happy Valley: AEZS $1.00 http://www.aezsinc.com/en/page.php?p=12 http://finance.yahoo.com/news/terna-Zentaris-Announces-prnews-3919667711.html?x= 0&.v=1 $1.33 RTQ...Traders starting to find these ...JMO DYODD
Posted by Free Muney on April 16, 2010 15:11 :
look at aezs go nuts! bets on monday?
Posted by Happy Valley on April 20, 2010 08:35 :
quote: Originally posted by Happy Valley: ARRY $2.77 http://www.arraybiopharma.com/ProductPipeline/Default.asp Array BioPharma Announces Eight Abstracts Selected for Presentation at 2010 AACR Annual Meetinghttp://finance.yahoo.com/news/Array-BioPharma-Announces-bw-1040372837.html?x=0&. v=1 Array BioPharma Signs Strategic Oncology Collaborationhttp://finance.yahoo.com/news/Array-BioPharma-Signs-bw-707932723.html?x=0&.v=1 $3.93 hitting in PM...
Posted by Happy Valley on April 20, 2010 13:58 :
BPAX $1.97 BioSante Pharmaceuticals, Inc. To Present and Participate in Cancer Immunotherapy Panel at the World Vaccine Congresshttp://finance.yahoo.com/news/BioSante-Pharmaceuticals-Inc-bw-4121799537.html?x= 0&.v=1
Posted by Happy Valley on April 20, 2010 16:11 :
quote: Originally posted by Happy Valley: DCTH $9.58 Delcath's Phase III Trial Data to be Presented During American Society of Clinical Oncology 2010 Annual Meeting in Chicagohttp://finance.yahoo.com/news/Delcaths-Phase-III-Trial-Data-prnews-220279443.htm l?x=0&.v=1 Delcath Systems, Inc.(NasdaqCM: DCTH) Real-Time: 10.53 0.64 (6.47%) 4:00pm ET Last Trade: 10.59 Trade Time: 3:55PM ET Change: 0.70 (7.08%) Prev Close: 9.89 Open: 10.00 Bid: 10.61 x 400 Ask: 10.62 x 2400 1y Target Est: 8.17 Day's Range: 9.94 - 10.74 52wk Range: 2.09 - 10.74 Volume: 1,894,171 Avg Vol (3m): 862,864 Market Cap: 384.53M P/E (ttm): N/A EPS (ttm): -0.82 Div & Yield: N/A (N/A
Posted by Happy Valley on April 21, 2010 09:06 :
IMMU $3.72...DYODDhttp://finance.yahoo.com/news/Immunomedics-Develops-Potent-pz-1816735072.html?x= 0&.v=1 http://finance.yahoo.com/news/Immunomedics-Reports-New-pz-1549513066.html?x=0&.v =1 http://finance.yahoo.com/news/Immunomedics-Reports-Progress-pz-187778937.html?x= 0&.v=1 http://finance.yahoo.com/news/Immunomedics-Develops-Novel-pz-4218566204.html?x=0 &.v=1 Almost forgot to add...IMMU is also going to be presenting full data phase IIb results for their Lupus drug Ipratuzumab in June...http://www.mystockbuddy.com/forum/biopharmaceutical_picks/2959-immunomedics_inc_ immu_nasdaq.html
Posted by Happy Valley on April 22, 2010 08:28 :
quote: Originally posted by Happy Valley: quote: Originally posted by Happy Valley: DCTH $9.58 Delcath's Phase III Trial Data to be Presented During American Society of Clinical Oncology 2010 Annual Meeting in Chicagohttp://finance.yahoo.com/news/Delcaths-Phase-III-Trial-Data-prnews-220279443.htm l?x=0&.v=1 Delcath Systems, Inc.(NasdaqCM: DCTH) Real-Time: 10.53 0.64 (6.47%) 4:00pm ET Last Trade: 10.59 Trade Time: 3:55PM ET Change: 0.70 (7.08%) Prev Close: 9.89 Open: 10.00 Bid: 10.61 x 400 Ask: 10.62 x 2400 1y Target Est: 8.17 Day's Range: 9.94 - 10.74 52wk Range: 2.09 - 10.74 Volume: 1,894,171 Avg Vol (3m): 862,864 Market Cap: 384.53M P/E (ttm): N/A EPS (ttm): -0.82 Div & Yield: N/A (N/A $14.60 going in PM... Delcath Phase III Trial Results Exceed Primary Endpoint Expectations Treatment Arm Shows More Than 3x Median hPFS Compared to Control Arm Conference Call Today at 5:15 p.m. ET http://finance.yahoo.com/news/Delcath-Phase-III-Trial-prnews-1882581301.html?x=0 &.v=1
Posted by Happy Valley on April 26, 2010 08:06 :
quote: Originally posted by Happy Valley: BPAX $1.97 BioSante Pharmaceuticals, Inc. To Present and Participate in Cancer Immunotherapy Panel at the World Vaccine Congresshttp://finance.yahoo.com/news/BioSante-Pharmaceuticals-Inc-bw-4121799537.html?x= 0&.v=1 BioSante Pharmaceuticals Enters Option Agreement to its 2A/Furin Antibody Expression Technologyhttp://finance.yahoo.com/news/BioSante-Pharmaceuticals-bw-2322914858.html?x=0&.v =1 $2.50 going in PM...
Posted by Free Muney on April 26, 2010 13:24 :
great thread happy. jumped on arry and bpax and did well on both!
Posted by Happy Valley on April 27, 2010 08:52 :
quote: Originally posted by Free Muney: great thread happy. jumped on arry and bpax and did well on both! Nice job!!!Glad you're making money here ...
Posted by Happy Valley on April 29, 2010 17:57 :
quote: Originally posted by Happy Valley: CLDX $6.88 Nice pipeline and has a history of popping into ASCO...DYODD http://www.celldextherapeutics.com/wt/page/trials_cancer Celldex Therapeutics, Inc(NasdaqGM: CLDX) After Hours: 7.81 0.03 (0.39%) 4:38PM EDT Last Trade: 7.78 Trade Time: 4:00PM EDT Change: 0.56 (7.76%) Prev Close: 7.22 Open: 7.20 Bid: 7.83 x 2000 Ask: 7.92 x 500 1y Target Est: 11.25 Day's Range: 7.19 - 8.05 52wk Range: 4.16 - 14.19 Volume: 1,862,479 Avg Vol (3m): 493,119 Market Cap: 246.71M P/E (ttm): N/A EPS (ttm): -1.84 Div & Yield: N/A (N/A
Posted by Happy Valley on April 29, 2010 18:13 :
quote: Originally posted by Happy Valley: quote: Originally posted by Happy Valley: KERXhttp://seekingalpha.com/article/198045-keryx-biopharmaceuticals-could-easily-tri ple-within-the-next-year KERX continuing to romp in AH's...Cancer plays will be hot up til ASCO...JMO DYODD Keryx Biopharmaceuticals, Inc.(NasdaqCM: KERX) After Hours: 4.55 0.28 (6.56%) 5:37pm ET Last Trade: 4.27 Trade Time: 4:00pm ET Change: 0.80 (23.05%) Prev Close: 3.47 Open: 3.72 Bid: 4.46 x 800 Ask: 4.58 x 1500 1y Target Est: 5.75 Day's Range: 3.70 - 4.30 52wk Range: 0.15 - 4.30 Volume: 13,341,371 Avg Vol (3m): 1,790,500 Market Cap: 242.80M P/E (ttm): 20.53 EPS (ttm): 0.21 Div & Yield: N/A (N/A Testing 52 week highs today... Keryx Biopharmaceuticals, Inc.(NasdaqCM: KERX) After Hours: 4.92 0.00 (0.00%) 5:55PM EDT Last Trade: 4.92 Trade Time: 4:00PM EDT Change: 0.69 (16.31%) Prev Close: 4.23 Open: 4.26 Bid: 4.86 x 1800 Ask: 4.93 x 6500 1y Target Est: 5.75 Day's Range: 4.25 - 4.98 52wk Range: 0.22 - 4.99 Volume: 5,471,323 Avg Vol (3m): 2,332,300 Market Cap: 279.76M P/E (ttm): 23.65 EPS (ttm): 0.21 Div & Yield:
Posted by Happy Valley on April 29, 2010 19:16 :
quote: Originally posted by Happy Valley: DCTH $9.58 Delcath's Phase III Trial Data to be Presented During American Society of Clinical Oncology 2010 Annual Meeting in Chicagohttp://finance.yahoo.com/news/Delcaths-Phase-III-Trial-Data-prnews-220279443.htm l?x=0&.v=1 Lets see if any DNDN money makes it's way over here now that Provenge got the FDA nod today...DYODDhttp://www.reuters.com/article/idCNN2919838820100429?rpc=44 Delcath Systems, Inc.(NasdaqCM: DCTH) After Hours: 16.25 0.07 (0.43%) 6:50PM EDT Last Trade: 16.18 Trade Time: 4:00PM EDT Change: 0.33 (2.08%) Prev Close: 15.85 Open: 16.25 Bid: 16.15 x 2100 Ask: 16.25 x 2500 1y Target Est: 18.63 Day's Range: 15.26 - 16.45 52wk Range: 2.15 - 16.45 Volume: 3,256,565 Avg Vol (3m): 1,345,060 Market Cap: 587.51M P/E (ttm): N/A EPS (ttm): -0.82 Div & Yield: N/A (N/A
Posted by Happy Valley on April 30, 2010 09:19 :
ASCO: Stocks With New Datahttp://www.thestreet.com/_yahoo/story/10741201/1/asco-stocks-with-new-data.html? cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
Posted by Happy Valley on April 30, 2010 09:51 :
KERX...$5.70 RTQ...New 52wk highs here...
Posted by Happy Valley on April 30, 2010 09:53 :
AEZS...Volume pouring in off KERX momo...
Posted by Happy Valley on May 01, 2010 19:08 :
RPTP $2.45...Completely missed this one but adding it to my watchlist...http://www.raptorpharma.com/products_overview.html http://finance.yahoo.com/news/Raptor-Pharmaceutical-pz-448576162.html?x=0&.v=1 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933http://www.sec.gov/Archives/edgar/data/1070698/000107069810000043/raptors1042210 .htm
Posted by Happy Valley on May 01, 2010 19:13 :
ZIOP $5.89...Not in but adding to my watchlist...DYODDhttp://www.ziopharm.com/clinical_dev.php ZIOPHARM Palifosfamide PICASSO Trial Abstract Selected for 2010 Best of ASCO® Meeting Programhttp://finance.yahoo.com/news/ZIOPHARM-Palifosfamide-bw-1584150691.html?x=0&.v=1 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933http://www.sec.gov/Archives/edgar/data/1070698/000107069810000043/raptors1042210 .htm
Posted by Happy Valley on May 01, 2010 19:36 :
INFI $6.90http://www.infi.com/pipeline.html http://seekingalpha.com/article/198621-infinity-pharmaceuticals-a-promising-unde rappreciated-cancer-drug-maker
Posted by Happy Valley on May 03, 2010 08:23 :
BPAX BioSante Pharmaceuticals Announces Reinitiation of Prostate Cancer Vaccine Developmenthttp://finance.yahoo.com/news/BioSante-Pharmaceuticals-bw-1326746823.html?x=0&.v =1
Posted by Happy Valley on May 03, 2010 10:17 :
quote: Originally posted by Happy Valley: RPTP $2.45...Completely missed this one but adding it to my watchlist... http://www.raptorpharma.com/products_overview.html http://finance.yahoo.com/news/Raptor-Pharmaceutical-pz-448576162.html?x=0&.v=1 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933http://www.sec.gov/Archives/edgar/data/1070698/000107069810000043/raptors1042210 .htm There she goes...$3.75 HOD http://finance.yahoo.com/news/Raptor-Pharmaceutical-pz-967910923.html?x=0&.v=1
Posted by Happy Valley on May 03, 2010 13:11 :
quote: Originally posted by Happy Valley: CYCC $2.39 http://www.cyclacel.com/cyc/ourcompany/pipeline/ Presenting at AACR April 17th-21st... Cyclacel Pharmaceuticals Announces Multiple Abstracts Selected for Presentation at American Association for Cancer Research Annual Meeting Translational Studies Highlight Unique Mechanism of Action and New Potential Clinical Applications for Sapacitabine and Seliciclib http://finance.yahoo.com/news/Cyclacel-Pharmaceuticals-pz-3996680954.html?x=0&.v =1 Added to the stash $2.31...
Posted by Happy Valley on May 03, 2010 18:23 :
quote: Originally posted by Happy Valley: KERX...$5.70 RTQ...New 52wk highs here... $6.35...Making new 52wk highs again in AH...
Posted by Happy Valley on May 04, 2010 09:54 :
quote: Originally posted by Happy Valley: quote: Originally posted by Happy Valley: CYCC $2.39 http://www.cyclacel.com/cyc/ourcompany/pipeline/ Presenting at AACR April 17th-21st... Cyclacel Pharmaceuticals Announces Multiple Abstracts Selected for Presentation at American Association for Cancer Research Annual Meeting Translational Studies Highlight Unique Mechanism of Action and New Potential Clinical Applications for Sapacitabine and Seliciclib http://finance.yahoo.com/news/Cyclacel-Pharmaceuticals-pz-3996680954.html?x=0&.v =1 Added to the stash $2.31... $2.51 HOD with volume...Traders finding it JMO DYODD...
Posted by Happy Valley on May 06, 2010 08:19 :
AEZS Aeterna Zentaris Receives Orphan-Drug Designation from the FDA for AEZS-108 in Ovarian Cancerhttp://finance.yahoo.com/news/Aeterna-Zentaris-Receives-prnews-1436938383.html?x =0&.v=1
Posted by Happy Valley on May 06, 2010 08:34 :
KERX Keryx Biopharmaceuticals Initiates Phase 3 Registration Program of Zerenex (ferric citrate) for the Treatment of Patients with Hyperphosphatemiahttp://finance.yahoo.com/news/Keryx-Biopharmaceuticals-prnews-3408417543.html?x= 0&.v=1
Posted by Happy Valley on May 06, 2010 08:54 :
CLDX Celldex Therapeutics Announces Presentation of Four Abstracts at ASCO 2010 Meetinghttp://finance.yahoo.com/news/Celldex-Therapeutics-prnews-1919097516.html?x=0&.v =1
Posted by Happy Valley on May 16, 2010 20:22 :
The 2010 Annual Meeting abstracts designated for Oral, Clinical Science Symposia, Poster Discussion, and General Poster Sessions will be publicly released on ASCO.org on Thursday, May 20, at 6:00 PM (EDT).http://chicago2010.asco.org/Abstracts/2010Abstracts.aspx Really looking foward to the next couple of weeks...GLTYA
Posted by Happy Valley on May 31, 2010 19:48 :
quote: Originally posted by Happy Valley: MYRX $4.98 http://www.myriadpharma.com/product-pipeline/clinical $4.02 RTQ...Trading at almost $2.00 under cash here...JMO DYODDhttp://www.sec.gov/Archives/edgar/data/1459450/000119312510122105/d10q.htm
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by Infopop Corporation
UBB.classic™
6.7.2